Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.

Moore KLF, Rognvaldsson S, Szabo AG, Vaitekėnaitė V, Loigom D, Genell A, Thorsen J, Norgaard JN, Thorsteinsdottir S, Knut-Bojanowska D, Lysen A, Schjesvold F, Peceliunas V, Kaare A, Palk K, Parnat M, Sigurdsson A, Vangsted AJ, Blimark CH, Study Group NM

Open source

DOI: 10.3324/haematol.2025.287344
Published: 2026 Feb 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2025.287344,
  title = {Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.},
  author = {Moore KLF and Rognvaldsson S and Szabo AG and Vaitekėnaitė V and Loigom D and Genell A and Thorsen J and Norgaard JN and Thorsteinsdottir S and Knut-Bojanowska D and Lysen A and Schjesvold F and Peceliunas V and Kaare A and Palk K and Parnat M and Sigurdsson A and Vangsted AJ and Blimark CH and Study Group NM},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2025.287344},
  url = {https://doi.org/10.3324/haematol.2025.287344}
}

RIS

TY  - JOUR
TI  - Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.
AU  - Moore KLF
AU  - Rognvaldsson S
AU  - Szabo AG
AU  - Vaitekėnaitė V
AU  - Loigom D
AU  - Genell A
AU  - Thorsen J
AU  - Norgaard JN
AU  - Thorsteinsdottir S
AU  - Knut-Bojanowska D
AU  - Lysen A
AU  - Schjesvold F
AU  - Peceliunas V
AU  - Kaare A
AU  - Palk K
AU  - Parnat M
AU  - Sigurdsson A
AU  - Vangsted AJ
AU  - Blimark CH
AU  - Study Group NM
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2025.287344
UR  - https://doi.org/10.3324/haematol.2025.287344
ER  -

APA

KLF, M., S, R., AG, S., V, V., D, L., A, G., J, T., JN, N., S, T., D, K., A, L., F, S., V, P., A, K., K, P., M, P., A, S., AJ, V., CH, B., & NM, S. G. (2026). Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.. Haematologica. https://doi.org/10.3324/haematol.2025.287344

Source records

pubmed · retrieved 2026-09-26T13:15:14.006Z